We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current SLDB market cap is 339.06M. The company's latest EPS is USD -2.5430 and P/E is -3.53.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -21.13M | -34.57M | -31.66M | -26.84M | -23.11M |
| Net Income | -20.41M | -15.15M | -30.07M | -24.63M | -20.98M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 13.62M | 8.09M | 0 |
| Operating Income | -119.32M | -88.41M | -72.25M | -106.45M | -104.25M |
| Net Income | -117.22M | -88.29M | -72.19M | -85.98M | -96.02M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 184.47M | 260.25M | 229.59M | 204.72M | 184.73M |
| Total Liabilities | 41.2M | 48.59M | 45.8M | 40.99M | 40.37M |
| Total Equity | 143.28M | 211.67M | 183.79M | 163.73M | 144.36M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 103.47M | 171.17M | 232.38M | 260.25M | 164.94M |
| Total Liabilities | 23.42M | 39.08M | 24.17M | 48.59M | 38.46M |
| Total Equity | 80.05M | 132.09M | 208.21M | 211.67M | 126.48M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -63.5M | -97.98M | -28M | -55.46M | -73.36M |
| Investing | -6.94M | 59.16M | 37.26M | -10.97M | -35.61M |
| Financing | 94k | 74.83M | N/A | 2.62M | 2.62M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -92.71M | -56.6M | -77.76M | -97.98M | -94.18M |
| Investing | 24.52M | 6.6M | -91.09M | 59.16M | 9.69M |
| Financing | 57.88M | 128.7M | 134.99M | 74.83M | 3.12M |
| Market Cap | 339.06M |
| Price to Earnings Ratio | -3.53 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.58 |
| Price to Book Ratio | 2.68 |
| Dividend Yield | - |
| Shares Outstanding | 37.76M |
| Average Volume (1 week) | 223.25k |
| Average Volume (1 Month) | 189.88k |
| 52 Week Change | 97.36% |
| 52 Week High | 15.05 |
| 52 Week Low | 1.81 |
| Spread (Intraday) | 2.06 (21.68%) |
| Company Name | Solid Biosciences Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.solidbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
